Ajanta Pharma Ltd
NSE :AJANTPHARM BSE :532331 Sector : PharmaceuticalsBuy, Sell or Hold AJANTPHARM? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
21 Mar 2714.10 (3.34%) | 20 Mar 2626.35 (0.15%) | 19 Mar 2622.50 (0.78%) | 18 Mar 2602.25 (0.99%) | 17 Mar 2576.85 (1.52%) | 13 Mar 2538.25 (-0.27%) | 12 Mar 2545.05 (1.47%) | 11 Mar 2508.10 (-0.56%) | 10 Mar 2522.25 (-1.58%) | 07 Mar 2562.85 (-0.25%) | 06 Mar 2569.40 (0.29%) | 05 Mar 2561.90 (4.61%) | 04 Mar 2448.90 (0.20%) | 03 Mar 2444.00 (-1.69%) | 28 Feb 2485.95 (-4.01%) | 27 Feb 2589.70 (0.16%) | 25 Feb 2585.50 (0.83%) | 24 Feb 2564.30 (-1.62%) | 21 Feb 2606.50 (-2.15%) | 20 Feb 2663.70 (-4.47%) | 19 Feb 2788.40 (1.16%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors

Very Bullish
Medium Term Investors

Neutral
Long Term Investors

Bearish
Moving Averages
5 DMA
Bullish
2631.33
10 DMA
Bullish
2583.98
20 DMA
Bullish
2571.07
50 DMA
Bullish
2670.45
100 DMA
Bearish
2800.82
200 DMA
Bearish
2816.26
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Mar 21, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 3105.16 | 2993.33 | 2783.25 | - | - |
R2 | 2993.33 | 2897.28 | 2760.2 | 2986.39 | - |
R1 | 2853.71 | 2837.93 | 2737.15 | 2839.83 | 2923.53 |
P | 2741.88 | 2741.88 | 2741.88 | 2734.94 | 2776.79 |
S1 | 2602.26 | 2645.83 | 2691.05 | 2588.38 | 2672.08 |
S2 | 2490.43 | 2586.48 | 2668 | 2483.49 | - |
S3 | 2350.81 | 2490.43 | 2644.95 | - | - |
Key Metrics
EPS
70.94
P/E
38.43
P/B
9.65
Dividend Yield
1.89%
Market Cap
33,902 Cr.
Face Value
2
Book Value
282.56
ROE
23.47%
EBITDA Growth
350.27 Cr.
Debt/Equity
0.01
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Ajanta Pharma Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 1118.74 | 1089.58 | 1171.39 | 1206.12 | 1176.57 | |
PROFIT | 210.03 | 202.72 | 245.77 | 216.48 | 232.88 | |
EPS | 16.68 | 16.1 | 19.54 | 17.27 | 18.6 |
Ajanta Pharma Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 1099.02 | 959.75 | 1105.64 | 1169.25 | 1135.15 | |
PROFIT | 220.15 | 162.69 | 236.03 | 234.98 | 252.45 | |
EPS | 17.48 | 12.92 | 18.77 | 18.75 | 20.16 |
Profit & Loss (Figures in Rs. Crores)
Ajanta Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 1483.02 | 1819.79 | 2017.74 | 2199.14 | 2133.06 | 2696.81 | 3066.57 | 3539.84 | 3815.52 | 4332.52 | |
PROFIT | 314.81 | 416.7 | 509.77 | 468.65 | 387.14 | 470.53 | 651.29 | 713.28 | 594.01 | 808.03 | |
EPS | 22.94 | 31.33 | 38.2 | 35.32 | 29.41 | 35.55 | 50.13 | 55.34 | 46.54 | 64.6 |
Ajanta Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 1380.68 | 1701.48 | 1863.99 | 1947.51 | 1942.15 | 2371.6 | 2896.76 | 3336.97 | 3566.01 | 4109.77 | |
PROFIT | 310.37 | 423.05 | 502.84 | 427.53 | 391.94 | 444.02 | 672.73 | 720.48 | 545.85 | 796.13 | |
EPS | 22.67 | 31.8 | 37.67 | 32.22 | 29.78 | 33.53 | 51.8 | 55.9 | 44.22 | 63.89 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.27 | 25.27 | 17.17 | 17.39 | 17.54 | 17.54 | 17.69 | 17.69 | 17.69 | 17.68 |
Reserves Total | 3,542.09 | 3,362.72 | 3,247.17 | 2,978.24 | 2,581.33 | 2,227.67 | 2,023.68 | 1,550 | 1,173.17 | 823.41 |
Total Shareholders Funds | 3,567.36 | 3,387.99 | 3,264.34 | 2,995.63 | 2,598.87 | 2,245.21 | 2,041.37 | 1,567.69 | 1,190.86 | 841.09 |
Secured Loans | 1.49 | 1.43 | 1.91 | 1.69 | 45.68 | 35.96 | 1.8 | 1.28 | 59.63 | 61.61 |
Unsecured Loans | 33.79 | 34.2 | 23.12 | 29.67 | 29.28 | 0 | 0 | 0 | 21.72 | 10.77 |
Total Debt | 35.28 | 35.63 | 25.03 | 31.36 | 74.96 | 35.96 | 1.8 | 1.28 | 81.35 | 72.38 |
Other Liabilities | 43.25 | 27.83 | 23.41 | 22.52 | 19.78 | 13.77 | 13.16 | 4.97 | 3.05 | 7.26 |
Total Liabilities | 3,645.89 | 3,451.45 | 3,312.78 | 3,049.51 | 2,693.61 | 2,294.94 | 2,056.33 | 1,573.94 | 1,275.26 | 920.73 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 2,389.41 | 2,282.82 | 2,217.79 | 2,140.78 | 1,976.15 | 1,593.35 | 1,417.23 | 879.01 | 715.73 | 549.85 |
Less: Accumulated Depreciation | 910.22 | 786.38 | 705.8 | 599.67 | 504.01 | 415.12 | 364.57 | 289.84 | 264.99 | 261.76 |
Net Block | 1,479.19 | 1,496.44 | 1,511.99 | 1,541.11 | 1,472.14 | 1,178.23 | 1,052.66 | 589.17 | 450.74 | 288.09 |
Capital Work in Progress | 256.45 | 209.47 | 152.86 | 108.19 | 131.86 | 261.61 | 61.33 | 339.26 | 239.8 | 170.2 |
Investments | 348.63 | 535.37 | 146.96 | 175.67 | 79.42 | 77.73 | 189.96 | 181.56 | 86.04 | 59.5 |
Inventories | 828.36 | 815.63 | 791.07 | 766.47 | 495.68 | 435.71 | 350.63 | 211.02 | 204.58 | 159.03 |
Sundry Debtors | 1,246.84 | 1,056.9 | 1,019.81 | 738.43 | 775.3 | 459.48 | 459.79 | 323.15 | 372.35 | 258.76 |
Cash and Bank Balance | 130.77 | 330.9 | 211.79 | 209.61 | 205.25 | 100.51 | 93.09 | 69.95 | 43.37 | 136.76 |
Loans and Advances | 194.9 | 120.3 | 119.93 | 137.41 | 98.34 | 119.37 | 137.73 | 64.92 | 66.19 | 59.4 |
Total Current Assets | 2,400.87 | 2,323.73 | 2,142.6 | 1,851.92 | 1,574.57 | 1,115.07 | 1,041.24 | 669.04 | 686.49 | 613.95 |
Current Liabilities | 821.47 | 1,082.76 | 622.18 | 576.41 | 523.06 | 334.67 | 312.79 | 224.27 | 182.06 | 146.16 |
Provisions | 62.53 | 47.09 | 18.75 | 60.63 | 20.86 | 7.67 | 32.47 | 22.15 | 11.35 | 64.3 |
Total Current Liabilities & Provisions | 884 | 1,129.85 | 640.93 | 637.04 | 543.92 | 342.34 | 345.26 | 246.42 | 193.41 | 210.46 |
Net Current Assets | 1,516.87 | 1,193.88 | 1,501.67 | 1,214.88 | 1,030.65 | 772.73 | 695.98 | 422.62 | 493.08 | 403.49 |
Deferred Tax Assets | 169.45 | 131.07 | 80.57 | 60.26 | 35.56 | 62.88 | 43.61 | 36.47 | 18.81 | 1.68 |
Deferred Tax Liability | 143.5 | 132.02 | 126.89 | 102.33 | 91.32 | 89.97 | 68 | 39.36 | 29.52 | 16.84 |
Net Deferred Tax | 25.95 | -0.95 | -46.32 | -42.07 | -55.76 | -27.09 | -24.39 | -2.89 | -10.71 | -15.16 |
Other Assets | 18.8 | 17.24 | 45.62 | 51.73 | 35.3 | 31.73 | 80.79 | 44.22 | 16.31 | 14.61 |
Total Assets | 3,645.89 | 3,451.45 | 3,312.78 | 3,049.51 | 2,693.61 | 2,294.94 | 2,056.33 | 1,573.94 | 1,275.26 | 920.73 |
Contingent Liabilities | 10.04 | 4.55 | 7.28 | 82.9 | 50.13 | 46.12 | 11.68 | 13.83 | 20.26 | 6.24 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.27 | 25.27 | 17.17 | 17.39 | 17.54 | 17.54 | 17.69 | 17.69 | 17.69 | 17.68 |
Reserves Total | 3,388.3 | 3,221.18 | 3,152.01 | 2,867.59 | 2,443.76 | 2,124.54 | 1,913.81 | 1,486.25 | 1,114.01 | 768.65 |
Total Shareholders Funds | 3,413.57 | 3,246.45 | 3,169.18 | 2,884.98 | 2,461.3 | 2,142.08 | 1,931.5 | 1,503.94 | 1,131.7 | 786.33 |
Secured Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.13 | 60.08 |
Unsecured Loans | 30.52 | 32.9 | 20.49 | 25.91 | 23.49 | 0 | 0 | 0 | 9.95 | 10.78 |
Total Debt | 30.52 | 32.9 | 20.49 | 25.91 | 23.49 | 0 | 0 | 0 | 68.08 | 70.86 |
Other Liabilities | 43.25 | 27.83 | 23.41 | 22.52 | 19.78 | 13.77 | 13.16 | 4.98 | 3.04 | 7.26 |
Total Liabilities | 3,487.34 | 3,307.18 | 3,213.08 | 2,933.41 | 2,504.57 | 2,155.85 | 1,944.66 | 1,508.92 | 1,202.82 | 864.45 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 2,355.33 | 2,246.28 | 2,163.18 | 2,086.54 | 1,926.65 | 1,555.61 | 1,379.38 | 843.35 | 679.21 | 510.92 |
Less : Accumulated Depreciation | 890.44 | 762.27 | 670.86 | 567.75 | 477.33 | 393.59 | 342.69 | 270.42 | 246.38 | 239.6 |
Net Block | 1,464.89 | 1,484.01 | 1,492.32 | 1,518.79 | 1,449.32 | 1,162.02 | 1,036.69 | 572.93 | 432.83 | 271.32 |
Capital Work in Progress | 256.45 | 209.47 | 152.86 | 108.19 | 131.06 | 261.29 | 61.33 | 339.26 | 239.8 | 170.2 |
Investments | 367.14 | 553.26 | 164.85 | 156.88 | 85.77 | 83 | 200.64 | 198.82 | 94.03 | 76.62 |
Inventories | 677.79 | 683.77 | 635.11 | 634.22 | 436.19 | 414.26 | 317.37 | 179.28 | 189.78 | 153.05 |
Sundry Debtors | 1,207.67 | 977.63 | 1,043.62 | 782.3 | 734.24 | 423.38 | 432.19 | 336 | 350.48 | 240.85 |
Cash and Bank Balance | 63.06 | 269.92 | 145.25 | 151.98 | 87.85 | 35.87 | 38.67 | 22.84 | 21.44 | 105.69 |
Loans and Advances | 163.1 | 109.6 | 111.17 | 128.72 | 89.66 | 110.21 | 124.4 | 55.39 | 59.94 | 53.98 |
Total Current Assets | 2,111.62 | 2,040.92 | 1,935.15 | 1,697.22 | 1,347.94 | 983.72 | 912.63 | 593.51 | 621.64 | 553.57 |
Current Liabilities | 566.54 | 874.39 | 446.8 | 459.91 | 444.53 | 299.09 | 279.48 | 191.4 | 175.93 | 141.94 |
Provisions | 55.06 | 25.5 | 18.74 | 46.57 | 18.89 | 7.67 | 20.71 | 20.84 | 11.36 | 64.3 |
Total Current Liabilities & Provisions | 621.6 | 899.89 | 465.54 | 506.48 | 463.42 | 306.76 | 300.19 | 212.24 | 187.29 | 206.24 |
Net Current Assets | 1,490.02 | 1,141.03 | 1,469.61 | 1,190.74 | 884.52 | 676.96 | 612.44 | 381.27 | 434.35 | 347.33 |
Deferred Tax Assets | 35 | 34.3 | 28.15 | 0 | 0 | 0 | 21 | 11.98 | 5.82 | 1.68 |
Deferred Tax Liability | 143.5 | 132.02 | 130.02 | 92.17 | 81.16 | 58.9 | 68 | 39.36 | 29.4 | 16.84 |
Net Deferred Tax | -108.5 | -97.72 | -101.87 | -92.17 | -81.16 | -58.9 | -47 | -27.38 | -23.58 | -15.16 |
Other Assets | 17.34 | 17.13 | 35.31 | 50.98 | 35.06 | 31.48 | 80.56 | 44.02 | 25.39 | 14.14 |
Total Assets | 3,487.34 | 3,307.18 | 3,213.08 | 2,933.41 | 2,504.57 | 2,155.85 | 1,944.66 | 1,508.92 | 1,202.82 | 864.45 |
Contingent Liabilities | 10.04 | 4.55 | 7.28 | 82.9 | 50.13 | 46.12 | 11.77 | 13.91 | 20.35 | 6.46 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 1,113.93 |
Depreciation | 135.4 |
Interest (Net) | 7.21 |
P/L on Sales of Assets | -3.49 |
P/L in Forex | -9.42 |
Others | -389.19 |
Total Adjustments (PBT and Ext... | 83.03 |
Operating Profit before Workin... | 1,196.96 |
Trade and 0ther Receivables | -178.88 |
Inventories | -12.3 |
Trade Payables | 40.85 |
Loans and Advances | -16.57 |
Total Adjustments (OP before W... | -99.76 |
Cash Generated from/(used in) ... | 1,097.2 |
Direct Taxes Paid | -312.13 |
Total Adjustments(Cash Generat... | -312.13 |
Cash Flow before Extraordinary... | 785.07 |
Net Cash from Operating Activi... | 785.07 |
Sale of Fixed Assets | 13.38 |
Purchase of Investments | -2,079.76 |
Sale of Investments | 2,257.39 |
Net Cash used in Investing Act... | 65.39 |
Proceed from 0ther Long Term B... | 0.06 |
Of Financial Liabilities | -16.23 |
Dividend Paid | -642.17 |
Interest Paid | -3.53 |
Net Cash used in Financing Act... | -1,051.06 |
Net Profit before Tax and Extr... | 1,096.95 |
Depreciation | 132.16 |
Interest (Net) | 6.8 |
Dividend Received | 29.13 |
P/L on Sales of Assets | -3.49 |
P/L in Forex | -9.42 |
Others | -389.2 |
Total Adjustments (PBT and Ext... | 49.31 |
Operating Profit before Workin... | 1,146.26 |
Trade and 0ther Receivables | -221.02 |
Inventories | 5.98 |
Trade Payables | 30.86 |
Loans and Advances | 1.61 |
Total Adjustments (OP before W... | -158.63 |
Cash Generated from/(used in) ... | 987.63 |
Direct Taxes Paid | -252.28 |
Total Adjustments(Cash Generat... | -252.28 |
Cash Flow before Extraordinary... | 735.35 |
Net Cash from Operating Activi... | 735.35 |
Sale of Fixed Assets | 12.18 |
Purchase of Investments | -2,079.76 |
Sale of Investments | 2,257.39 |
Interest Received | 38.21 |
Net Cash used in Investing Act... | 105.02 |
Of Financial Liabilities | -12.91 |
Dividend Paid | -642.17 |
Interest Paid | -3.42 |
Net Cash used in Financing Act... | -1,047.7 |
Company Details
Registered Office |
|
Address | Ajanta House, Charkop Kandivli (W) |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66061000/1204/1203 |
Fax. No. | 91-22-66061200/1300 |
info@ajantapharma.com; investorgrievance@ajantapha | |
Internet | http://www.ajantapharma.com |
Registrars |
|
Address | Ajanta House |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66061000/1204/1203 |
Fax. No. | 91-22-66061200/1300 |
info@ajantapharma.com; investorgrievance@ajantapha | |
Internet | http://www.ajantapharma.com |
Management |
|
Name | Designation |
Mannalal B Agrawal | Chairman (Non-Executive) |
Madhusudan B Agrawal | Vice Chairman |
Yogesh Agrawal | Managing Director |
Chandrakanth M Khetan | Independent Director |
Gaurang Shah | Vice President & CS |
Rajesh M Agrawal | Joint Managing Director |
K H Viswanathan | Independent Director |
Prabhakar Dalal | Independent Director |
Anjana Grewal | Independent Director |
David Rasquinha | Independent Director |
Medha Joshi | Independent Director |
Simi Thapar | Independent Director |
Rajesh Shashikant Dalal | Independent Director |